|
RAD54L2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.84640000000513E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.11139999994892E-06 |
| Normal-vs-Stage2 |
1.022310E-03 |
| Normal-vs-Stage3 |
1.809710E-04 |
| Normal-vs-Stage4 |
6.28699999999371E-05 |
| Stage1-vs-Stage2 |
9.153600E-01 |
| Stage1-vs-Stage3 |
7.057200E-01 |
| Stage1-vs-Stage4 |
2.581400E-01 |
| Stage2-vs-Stage3 |
8.430000E-01 |
| Stage2-vs-Stage4 |
3.198200E-01 |
| Stage3-vs-Stage4 |
3.755200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.64449999968164E-07 |
| Normal-vs-AfricanAmerican |
6.174200E-04 |
| Normal-vs-Asian |
1.4058999964206E-08 |
| Caucasian-vs-AfricanAmerican |
6.235600E-01 |
| Caucasian-vs-Asian |
9.639500E-04 |
| AfricanAmerican-vs-Asian |
1.259860E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.06610000009056E-08 |
| Normal-vs-Female |
1.380420E-01 |
| Male-vs-Female |
1.259380E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.823100E-03 |
| Normal-vs-Extreme_Weight |
1.90050000181685E-08 |
| Normal-vs-Obese |
8.233300E-04 |
| Normal-vs-Extreme_Obese |
1.224400E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.987040E-01 |
| Normal_Weight-vs-Obese |
6.225400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.442200E-01 |
| Extreme_Weight-vs-Obese |
9.060100E-03 |
| Extreme_Weight-vs-Extreme_Obese |
5.920600E-01 |
| Obese-vs-Extreme_Obese |
4.234600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.645800E-02 |
| Normal-vs-Age(41-60Yrs) |
4.449100E-04 |
| Normal-vs-Age(61-80Yrs) |
1.58229999991377E-07 |
| Normal-vs-Age(81-100Yrs) |
4.34960000017526E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.742600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.831190E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.041500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.402200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.902660E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.290840E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.0891000002995E-07 |
| Normal-VS-Type2 PRCC |
2.09109999999013E-05 |
| Normal-VS-KIRP CIMP |
4.406400E-01 |
| Normal-VS-Unclassified PRCC |
1.912040E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.012200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.504400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.510100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.716830E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.494400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.044400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.78180004084538E-09 |
| Normal-vs-N1 |
2.482600E-03 |
| Normal-vs-N2 |
5.663900E-02 |
| N0-vs-N1 |
3.755800E-01 |
| N0-vs-N2 |
5.189800E-01 |
| N1-vs-N2 |
9.606200E-01 |
|
|
